Glessner Coleen
- SEC CIK
- 0001919170
In the past year, 1 open-market sale filing worth $306.1K and no purchases.
Current role at each company
- EBS Emergent BioSolutions Inc.EVP, Quality & Ethics, and CPLas of Jun 10, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $306.1K
- 1 filing
- Net
- −$306.1K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Glessner Coleen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Oct 16, 2025 (view filing) | Oct 7 | 9 daysLate | Glessner ColeenEVP, Quality & Ethics, and CPL | SSale | −30.6K | $10.00 | −$306.1K | −17.5%144.3K after |